NO20051841D0 - Fremgangsmate for a oke produksjon av blodplater og hematopoietiske stamceller. - Google Patents

Fremgangsmate for a oke produksjon av blodplater og hematopoietiske stamceller.

Info

Publication number
NO20051841D0
NO20051841D0 NO20051841A NO20051841A NO20051841D0 NO 20051841 D0 NO20051841 D0 NO 20051841D0 NO 20051841 A NO20051841 A NO 20051841A NO 20051841 A NO20051841 A NO 20051841A NO 20051841 D0 NO20051841 D0 NO 20051841D0
Authority
NO
Norway
Prior art keywords
stem cells
hematopoietic stem
platelet production
increasing platelet
increasing
Prior art date
Application number
NO20051841A
Other languages
English (en)
Other versions
NO20051841L (no
NO333928B1 (no
Inventor
Kenneth Kaushansky
Brian R Macdonald
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NO20051841D0 publication Critical patent/NO20051841D0/no
Publication of NO20051841L publication Critical patent/NO20051841L/no
Publication of NO333928B1 publication Critical patent/NO333928B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/196—Thrombopoietin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO20051841A 2002-09-18 2005-04-15 Anvendelse av TPO etterligningsforbindelser for fremstilling av en farmasøytisk sammensetning for å øke produksjonen av blodplater og hematopoietiske stamceller. NO333928B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41177902P 2002-09-18 2002-09-18
US41170002P 2002-09-18 2002-09-18
PCT/US2003/029701 WO2004026332A1 (en) 2002-09-18 2003-09-18 Methods of increasing platelet and hematopoietic stem cell production

Publications (3)

Publication Number Publication Date
NO20051841D0 true NO20051841D0 (no) 2005-04-15
NO20051841L NO20051841L (no) 2005-06-16
NO333928B1 NO333928B1 (no) 2013-10-21

Family

ID=32033567

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051841A NO333928B1 (no) 2002-09-18 2005-04-15 Anvendelse av TPO etterligningsforbindelser for fremstilling av en farmasøytisk sammensetning for å øke produksjonen av blodplater og hematopoietiske stamceller.

Country Status (19)

Country Link
US (2) US8067367B2 (no)
EP (2) EP1542714B1 (no)
JP (2) JP2005539082A (no)
KR (1) KR20050093759A (no)
AU (2) AU2003275077B2 (no)
BR (1) BR0314591A (no)
CA (1) CA2499625A1 (no)
DK (1) DK1542714T3 (no)
EA (1) EA010759B1 (no)
ES (2) ES2462916T3 (no)
HR (1) HRP20050265B1 (no)
IL (1) IL167498A (no)
IS (1) IS7756A (no)
MX (1) MXPA05003057A (no)
NO (1) NO333928B1 (no)
NZ (1) NZ566812A (no)
PL (1) PL376085A1 (no)
PT (1) PT1542714E (no)
WO (1) WO2004026332A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091311B2 (en) 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
PL376085A1 (en) 2002-09-18 2005-12-12 Ortho-Mcneil Pharmaceutical, Inc. Methods of increasing platelet and hematopoietic stem cell production
BRPI0414008B8 (pt) * 2003-08-28 2021-05-25 Ortho Mcneil Pharm Inc compostos que se ligam a um receptor de trombopoietina, composições e métodos in vitro para ativação de um receptor de trombopoietina em uma célula
US7723295B2 (en) * 2003-08-28 2010-05-25 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to a receptor
TW200530269A (en) 2003-12-12 2005-09-16 Chugai Pharmaceutical Co Ltd Anti-Mpl antibodies
US7615533B2 (en) 2004-08-16 2009-11-10 Janssen Pharmaceutica N.V. TPO peptide compounds for treatment of anemia
US9493569B2 (en) 2005-03-31 2016-11-15 Chugai Seiyaku Kabushiki Kaisha Structural isomers of sc(Fv)2
AU2006256041B2 (en) 2005-06-10 2012-03-29 Chugai Seiyaku Kabushiki Kaisha Stabilizer for protein preparation comprising meglumine and use thereof
JP5085322B2 (ja) 2005-06-10 2012-11-28 中外製薬株式会社 ｓｃ（Ｆｖ）２を含有する医薬組成物
AU2007208226A1 (en) * 2006-01-25 2007-08-02 Amgen Inc. Thrombopoietic compounds
PT1984014E (pt) * 2006-02-14 2014-11-13 Janssen Pharmaceutica Nv Utilização de compostos de péptidos tpo e composições farmacêuticas no tratamento da anemia
KR20090021217A (ko) * 2006-06-14 2009-02-27 추가이 세이야쿠 가부시키가이샤 조혈 줄기세포 증가 촉진제
WO2013155347A1 (en) * 2012-04-11 2013-10-17 Izumi Raquel Bruton's tyrosine kinase inhibitors for hematopoietic mobilization
US20170191057A1 (en) * 2014-02-05 2017-07-06 Regents Of The University Of California Rna editing biomarkers for diagnosis, pharmacological screening and prognostication in cancer
KR20170109541A (ko) * 2014-12-12 2017-09-29 커먼웰쓰 사이언티픽 앤 인더스트리알 리서치 오거니제이션 알파9 인테그린 길항제를 사용한 골수 줄기 세포 니치로부터의 hsc의 이탈 및 방출
EP3312270B1 (en) * 2015-06-16 2020-09-30 Kyoto University High-performance platelet manufacturing method
US20230104658A1 (en) * 2021-10-01 2023-04-06 Janssen Pharmaceutica Nv Methods of increasing progenitor cell production
WO2024095178A1 (en) 2022-11-01 2024-05-10 Janssen Pharmaceutica Nv Thrombopoietin mimetic for use in the treatment of acute liver failure

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3654090A (en) 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4668619A (en) 1980-10-30 1987-05-26 Miles Laboratories, Inc. Multilayer homogeneous specific binding assay device
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4563303A (en) 1984-04-14 1986-01-07 Judicial Foundation The Chemosero-Therapeutic Research Institute Method for purification of filamentous hemagglutinin
US4612132A (en) 1984-07-20 1986-09-16 Chevron Research Company Modified succinimides
DE3675588D1 (de) 1985-06-19 1990-12-20 Ajinomoto Kk Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
GB8601279D0 (en) 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
GB2186579B (en) 1986-01-21 1990-07-25 Brian Maurice John Foxwell Improvements relating to the radio-labelling of proteins
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
GB8807860D0 (en) 1988-04-05 1988-05-05 Connaught Lab Pertussis vaccine
US5198424A (en) 1989-03-08 1993-03-30 Board Of Regents Of The University Of Oklahoma Functionally active selectin-derived peptides
US5424186A (en) 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5326558A (en) 1989-08-08 1994-07-05 Genetics Institute, Inc. Megakaryocytopoietic factor
IL96477A0 (en) 1989-12-01 1991-08-16 Amgen Inc Megakaryocyte production
DK167813B1 (da) 1989-12-07 1993-12-20 Carlbiotech Ltd As Pentapeptidderivat, farmaceutisk acceptable salte heraf, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
US5571508A (en) 1989-12-18 1996-11-05 Amrad Corporation Limited Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor
IT1241395B (it) 1990-04-02 1994-01-10 Eniricerche Spa Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
US5141851A (en) 1990-04-18 1992-08-25 Board Of Regents, The University Of Texas System Isolated farnesyl protein transferase enzyme
US5723286A (en) 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
US5250732A (en) 1991-07-18 1993-10-05 Genentech, Inc. Ketamine analogues for treatment of thrombocytopenia
US5639603A (en) 1991-09-18 1997-06-17 Affymax Technologies N.V. Synthesizing and screening molecular diversity
DE69217497T2 (de) 1991-09-18 1997-06-12 Affymax Tech Nv Verfahren zur synthese der verschiedenen sammlungen von oligomeren
US5270170A (en) 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
US5359115A (en) 1992-03-26 1994-10-25 Affymax Technologies, N.V. Methods for the synthesis of phosphonate esters
WO1993025221A1 (en) 1992-06-11 1993-12-23 Alkermes Controlled Therapeutics, Inc. Erythropoietin drug delivery system
US5420328A (en) 1992-09-11 1995-05-30 Affymax Technologies, N.V. Methods for the synthesis of phosphonate esters
JP3401005B2 (ja) 1992-12-11 2003-04-28 ユニバーシティ オブ フロリダ 有害生物の防除のための材料および方法
US5354934A (en) 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
EP0722331A4 (en) 1993-08-25 1997-10-01 Systemix Inc METHOD FOR PRODUCING A POPULATION OF HIGHLY ENRICHED HEMATOPOIETIC STEM CELLS
WO1995011922A1 (en) 1993-10-29 1995-05-04 Affymax Technologies N.V. In vitro peptide and antibody display libraries
SG47030A1 (en) 1994-01-03 1998-03-20 Genentech Inc Thrombopoietin
CA2169173C (en) 1994-02-14 2002-10-15 Kenneth Kaushansky Methods for stimulating erythropoiesis using thrombopoietin
WO1995021919A2 (en) 1994-02-14 1995-08-17 Kirin Brewery Company, Limited Protein having tpo activity
CA2183266A1 (en) 1994-02-14 1995-08-17 Richard D. Holly Hematopoietic protein and materials and methods for making it
SG79882A1 (en) 1994-02-14 2001-04-17 Kirin Brewery Protein having tpo activity
CA2167090C (en) 1994-03-31 2002-05-14 Timothy D. Bartley Compositions and methods for stimulating megakaryocyte growth and differentiation
US5571686A (en) 1994-04-14 1996-11-05 Massachusetts Institute Of Technology Method of using megapoietin for prolonging the survival & viability of platlets
US5989833A (en) 1994-09-20 1999-11-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods for detection of molecules with affinity for MPL polypeptides
ATE190304T1 (de) 1994-11-04 2000-03-15 Santen Pharmaceutical Co Ltd Neue hydroxy-substituierte 1,3-dialkyl- harnstoffderivate
US5641655A (en) 1994-11-30 1997-06-24 Zymogenetics, Inc. Methods for producing thrombopoietin polypeptides using a mammalian tissue plasminogen activator secretory peptide
WO1996017062A1 (en) 1994-11-30 1996-06-06 Zymogenetics, Inc. Low molecular weight thrombopoietin
AU705064B2 (en) 1995-04-26 1999-05-13 Kyowa Hakko Kogyo Co. Ltd. Novel polypeptides
US6251864B1 (en) * 1995-06-07 2001-06-26 Glaxo Group Limited Peptides and compounds that bind to a receptor
YU34196A (sh) 1995-06-07 1999-03-04 Glaxo Group Limited Peptidi i jedinjenja koja se vezuju za receptor
US5869451A (en) * 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
IL122102A (en) 1995-06-07 2002-07-25 Glaxo Group Ltd Peptides and compounds bound to the thrombopoietin receptor, pharmaceutical preparations containing them and their use as medicinal substances
US6013067A (en) * 1995-06-07 2000-01-11 Zymogenetics, Inc. Methods for increasing hematopoietic cells
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
US20020187124A1 (en) 1995-09-27 2002-12-12 The General Hospital Corporation, A Massachusetts Corporation Asialocytokines and treatment of liver disease
US6060052A (en) * 1995-10-30 2000-05-09 Systemix, Inc. Methods for use of Mpl ligands with primitive human hematopoietic stem cells
US7091311B2 (en) * 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
US5932546A (en) 1996-10-04 1999-08-03 Glaxo Wellcome Inc. Peptides and compounds that bind to the thrombopoietin receptor
PT1124961E (pt) * 1998-10-23 2007-02-28 Amgen Inc Compostos trombopoiéticos
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
WO2000044398A2 (en) * 1999-01-28 2000-08-03 Board Of Regents, The University Of Texas System Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions
AU771460B2 (en) * 1999-09-24 2004-03-25 Smithkline Beecham Corporation Thrombopoietin mimetics
EP1149906A1 (en) * 2000-04-25 2001-10-31 Pliva, Farmaceutska, Industrija, Dionicko Drustvo Thrombopoietin receptor modulating peptide
JP2003535144A (ja) 2000-06-07 2003-11-25 アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ 多能性造血幹細胞の流動を刺激するヒト成長ホルモン
RU2276156C2 (ru) 2000-12-22 2006-05-10 Ипсен Мануфэкчуринг Ирленд Лимитед Способ синтеза пептида, содержащего остаток триптофана
KR100793508B1 (ko) 2001-03-22 2008-01-14 유오피 엘엘씨 입방 결정 모폴로지를 갖는 금속 인산알루미늄 분자체 및이를 사용한 메탄올의 올레핀으로의 전환 방법
AU2002307062A1 (en) * 2001-04-02 2002-10-15 Purdue Pharma L.P. Thrombopoietin (tpo) synthebody for stimulation of platelet production
PL376085A1 (en) 2002-09-18 2005-12-12 Ortho-Mcneil Pharmaceutical, Inc. Methods of increasing platelet and hematopoietic stem cell production
BRPI0414008B8 (pt) * 2003-08-28 2021-05-25 Ortho Mcneil Pharm Inc compostos que se ligam a um receptor de trombopoietina, composições e métodos in vitro para ativação de um receptor de trombopoietina em uma célula
US7723295B2 (en) * 2003-08-28 2010-05-25 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to a receptor
US20060210542A1 (en) * 2004-08-16 2006-09-21 Yurkow Edward J Use of TPO mimetic compounds and pharmaceutical compositions in the treatment of anemia
US7615533B2 (en) * 2004-08-16 2009-11-10 Janssen Pharmaceutica N.V. TPO peptide compounds for treatment of anemia
AU2009256465B2 (en) * 2008-06-03 2015-05-14 Janssen Pharmaceutica Nv TPO mimetic peptide for preventing hematological disorder associated with cancer treatment
JP5128668B2 (ja) * 2008-08-22 2013-01-23 シャープ株式会社 画像信号処理装置、画像信号処理方法、画像表示装置、テレビジョン受像機、電子機器

Also Published As

Publication number Publication date
AU2010200100B2 (en) 2013-05-23
US8283313B2 (en) 2012-10-09
NO20051841L (no) 2005-06-16
NZ566812A (en) 2009-07-31
IL167498A (en) 2014-01-30
AU2010200100A1 (en) 2010-01-28
PL376085A1 (en) 2005-12-12
AU2003275077A1 (en) 2004-04-08
HRP20050265A2 (en) 2006-06-30
EA010759B1 (ru) 2008-10-30
NO333928B1 (no) 2013-10-21
ES2462916T3 (es) 2014-05-26
ES2781475T3 (es) 2020-09-02
EP2319528A2 (en) 2011-05-11
EP2319528B8 (en) 2020-03-04
US20110288019A1 (en) 2011-11-24
JP2005539082A (ja) 2005-12-22
EP1542714B1 (en) 2014-04-02
IS7756A (is) 2005-03-17
US20050282277A1 (en) 2005-12-22
US8067367B2 (en) 2011-11-29
MXPA05003057A (es) 2006-04-18
DK1542714T3 (da) 2014-05-26
JP2011057690A (ja) 2011-03-24
EP2319528B1 (en) 2020-01-22
WO2004026332A1 (en) 2004-04-01
PT1542714E (pt) 2014-06-23
KR20050093759A (ko) 2005-09-23
CA2499625A1 (en) 2004-04-01
EA200500375A1 (ru) 2006-06-30
EP2319528A3 (en) 2011-08-31
EP1542714A1 (en) 2005-06-22
HRP20050265B1 (hr) 2016-05-20
BR0314591A (pt) 2005-08-09
AU2003275077B2 (en) 2010-02-04

Similar Documents

Publication Publication Date Title
NO20051841D0 (no) Fremgangsmate for a oke produksjon av blodplater og hematopoietiske stamceller.
EG23481A (en) Bimodal polyolefin production process.
DK1654438T3 (da) Fremgangsmåde til naturgasproduktion
ATE547171T1 (de) Brennstoffkassetten für brennstoffzellen und herstellungsverfahren dafür
HK1062331A1 (en) Magnetic sensor, production process of the magnetic sensor and magnetic array suitable for the production process
ZA200803268B (en) Plants having increased yield and a method for making the same
AU2003304243A1 (en) Process for the production of a fertilizer and fertilizer
DE50313510D1 (de) Zellkultureinsatz
NO20054490D0 (no) Planteceller og planter med okt toleranse for miljobetinget stress
IS7980A (is) Díarýlmetýlídenpíperidínafleiður, framleiðsla þeirra og notkun
IS8184A (is) Aðferð við framleiðslu á handhverfulega hreinu mírtasapíni
AU2003216822A8 (en) Stem cell culture
DE60318521D1 (de) Propfmodifiziertes Polypropylen und dessen Herstellungsverfahren
DK1668125T3 (da) Modificerede enzymer, fremgangsmåde til fremstilling af modificerede enzymer og anvendelser deraf
EP1568691A4 (en) ACCELERATOR FOR ERYTHROPOETIN PRODUCTION
NO20041737L (no) Fremgangsmate for a amplifisere hematopoetiske stamceller.
ZA200704605B (en) Plants having increased yield and method for making the same
DK1504104T3 (da) Insektresistente planter og fremgangsmåde til fremstilling deraf
EG24556A (en) Plant for urea production
AU2003210268A1 (en) Production of dadzein in transgenic plants
AU2003288532A8 (en) Process for manufacturing fibrin membranes
ES1052273Y (es) Bozal anti-estres.
AU2002349829A1 (en) Production process for plant biomass and its use
SI1542714T1 (sl) Postopki za povečanje proizvodnje krvnih ploščic in hematopoetskih matičnih celic
NO20053270D0 (no) Fremgangsmate og anlegg for styring av prosessforholdene i en reaktor.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees